| 2024/04/18 16:04:15 | |
|---|---|
| Price | |
| 36.24 EUR | |
| Difference | 3.57% (1.25) |
General attributes
| ISIN | DE0005785802 |
| Symbol | FME |
| Exchange | Frankfurt |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 10,689 EUR |
| Benchmark | GERMANY DAX |
Market data
| Bid (Bid size) | - |
| Ask (Ask size) | - |
| Open | 35.53 EUR |
| High | 36.24 EUR |
| Low | 35.53 EUR |
| Close (prev. day) | 34.99 EUR |
| VWAP | 36.16242 EUR |
| Volume (pcs) | 149 |
| Trading volume | 5,388.20 |
| Number of trades | 3 |
| Last size | 100 |
Futures and Options
| Related Futures | 38 |
| Related Options | - |
PDF Downloads
| Company report: FRESENIUS MEDICAL |  |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2024/04/03 |
|
Global Equity Ratings |
|
| 2024/03/13 |
|
Global Equity Ratings |
|
| 2024/02/22 |
|
Global Equity Ratings |
|
| 2024/02/14 |
|
Global Equity Ratings |
|
| 2024/01/23 |
|
Global Equity Ratings |
|
| 2024/04/18 16:04:15 | |
|---|---|
| Price | |
| 36.24 EUR | |
| Difference | 3.57% (1.25) |
General attributes
| ISIN | DE0005785802 |
| Symbol | FME |
| Exchange | Frankfurt |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 10,689 EUR |
| Benchmark | GERMANY DAX |
Market data
| Bid (Bid size) | - |
| Ask (Ask size) | - |
| Open | 35.53 EUR |
| High | 36.24 EUR |
| Low | 35.53 EUR |
| Close (prev. day) | 34.99 EUR |
| VWAP | 36.16242 EUR |
| Volume (pcs) | 149 |
| Trading volume | 5,388.20 |
| Number of trades | 3 |
| Last size | 100 |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | +9.82% | -12.10% | -42.88% |
| Perf (abs.) | +3.24 | -4.99 | -27.20 |
| Beta | 0.92 | 0.74 | 0.58 |
| Volatility | 36.11 | 37.81 | 33.62 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 35.35 EUR (599) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 35.59 EUR (476) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 36.59 EUR (472) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 39.41 EUR (645) |
| YTD High | date | 41.10 EUR (2024/02/20) |
| YTD Low | date | 34.26 EUR (2024/03/04) |
| 52 Weeks High | date | 49.45 EUR (2023/07/20) |
| 52 Weeks Low | date | 30.92 EUR (2023/10/11) |
All listings for FRESENIUS MEDICAL
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Xetra | 2024/04/18 | 17:36 | 36.43 EUR | 24.11 | 2,629 |
| Vienna Stock Exchange | 2024/04/18 | 17:32 | 36.47 EUR | 0.00 | 2 |
| Tradegate | 2024/04/18 | 22:26 | 36.36 EUR | 0.30 | 72 |
| Stuttgart | 2024/04/18 | 21:55 | 36.43 EUR | 0.01 | 66 |
| SIX Swiss Exchange | 2019/06/25 | 17:31 | 75.28 CHF | 0.02 | 3 |
| SIX Swiss Exchange | - | - | - | 0.00 | - |
| Munich | 2024/04/18 | 08:00 | 35.52 EUR | 0.00 | 2 |
| London Stock Exchange European Trade Reporting | 2024/04/18 | 17:30 | 36.33 EUR | 0.00 | 2 |
| Hanover | 2024/04/18 | 15:43 | 35.89 EUR | 0.00 | 2 |
| Hamburg | 2024/04/18 | 11:29 | 35.86 EUR | 0.00 | 2 |
| Frankfurt | 2024/04/18 | 16:04 | 36.24 EUR | 0.01 | 3 |
| FINRA other OTC Issues | 2024/04/12 | 20:52 | 36.95 USD | 0.01 | 2 |
| Euronext Milan MTF Trading After Hours | 2024/04/18 | 17:44 | 36.42 EUR | 0.00 | 1 |
| Euronext Milan MTF Global Equity Market | 2024/04/18 | 17:44 | 36.42 EUR | 0.00 | 1 |
| Duesseldorf | 2024/04/18 | 19:31 | 36.23 EUR | 0.00 | 5 |
| Berlin | 2024/04/18 | 21:52 | 36.37 EUR | 0.00 | 17 |
Company Logo
Contact Details
| FRESENIUS MEDICAL CARE AG |
| - - |
| Else-Kröner-Strasse 1 - 61352 Bad Homburg |
| Telefon: +49-6172-609-0 |
| Fax: + |
| E-mail: marketing.international@freseniusmedicalcare.com |
PDF Downloads
| Company report: FRESENIUS MEDICAL | |
Company Profile
Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. It operates through the Care Enablement and Care Delivery segments. The Care Enablement segment is involved in the healthcare products business including research and development, manufacturing, supply chain, and commercial operations as well as supporting functions, such as regulatory and quality management. The Care Delivery segment focuses on the health care services for the treatment of CKD, ESRD, and other extracorporeal therapies, including value and risk-based care programs. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany. |
Members of Management Board
| Helen Ping Giza | Chairman of Managing Board |
| Frank Maddux | Member of Executive Committee |
| Craig Cordola | Member of Executive Committee |
| M.D.,Ph.D. Katarzyna Mazur-Hofsaess | Member of Executive Committee |
| Martin Fischer | Member of Executive Committee |
Board of directors
| Michael Sen | Chairman of Supervisory Board |
| A. Sorensen | Member of Supervisory Board |
| Manuela Stauss-Grabo | Member of Supervisory Board |
| Marcus Kuhnert | Member of Supervisory Board |
| Beate Haßdenteufel | Member of Supervisory Board |
| Frank Prescher | Member of Supervisory Board |
| Pascale Witz | Member of Supervisory Board |
| Ralf Erkens | Member of Supervisory Board |
| Regina Karsch | Member of Supervisory Board |
| Sara Hennicken | Member of Supervisory Board |
| Shervin Korangy | Member of Supervisory Board |
| Stefanie Lang | Member of Supervisory Board |